Medpace Holdings, Inc. (MEDP) fundamentals score
Medpace Holdings is one of the world’s leading clinical contract research organizations, or CROs, by revenue, solely focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries.
Services-Commercial Physical & Biological Research · Industrials · Listed on NASDAQ
Overall: 8.0 out of 10, Strong long-term fundamentals
- Growth: 7.0/10
- Profitability: 8.2/10
- Financial health: 9.1/10
- Earnings quality: 9.6/10
- Valuation: 6.3/10
Scores are calculated from Medpace Holdings, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Industrials stocks
- Sezzle Inc. (SEZL): 9.1/10
- Paymentus Holdings, Inc. (PAY): 8.7/10
- Argan Inc. (AGX): 8.6/10
- Ferguson Enterprises Inc. (FERG): 8.6/10
- International Seaways, Inc. (INSW): 8.6/10
- Dorian Lpg Ltd. (LPG): 8.6/10
- Quinstreet, Inc. (QNST): 8.6/10
- Remitly Global, Inc. (RELY): 8.6/10